APA (7th ed.) Citation

W, X., A, G., M, W., L, H., C, M., Z, L., . . . L, Z. (2023). Assigning pathogenicity for TAB2 variants using a novel scalable functional assay and expanding TAB2 disease spectrum. Human molecular genetics, 32(6), 959. https://doi.org/10.1093/hmg/ddac252

Chicago Style (17th ed.) Citation

W, Xu, et al. "Assigning Pathogenicity for TAB2 Variants Using a Novel Scalable Functional Assay and Expanding TAB2 Disease Spectrum." Human Molecular Genetics 32, no. 6 (2023): 959. https://doi.org/10.1093/hmg/ddac252.

MLA (9th ed.) Citation

W, Xu, et al. "Assigning Pathogenicity for TAB2 Variants Using a Novel Scalable Functional Assay and Expanding TAB2 Disease Spectrum." Human Molecular Genetics, vol. 32, no. 6, 2023, p. 959, https://doi.org/10.1093/hmg/ddac252.